New research shows patient fears will limit the return to surgery
|
|
As the coronavirus pandemic began to spread, most hospitals stopped doing elective surgeries to create capacity for the surge of infected patients.
Now, as most states begin to reopen businesses, over 90% of hospitals have restarted these surgeries, and those that haven’t will do so within weeks.
|
|
Virtual learning makes learning and earning credit hours easier and more cost-effective. You get great speakers, informative presentations, and
46.75
credit hours from one virtual meeting. No travel. Just watch from your home or office. ASIPP® is offering a series of virtual courses like the upcoming,
Board Review Course, July 17-19
and
July 24-26, 2020.
We hope you'll review the
schedule
and decide to
register
. Please join us.
|
|
COVID-19: 'Nowhere Near the
End of the Mitigation Phase'
Former CDC head warns senators that pandemic is not in the past yet
This is not "the pandemic of a century" but "a harbinger of things to come," a former CDC director told members of the Senate Health, Education, Labor and Pensions (HELP) Committee during a hearing Tuesday.
The warning from Julie Gerberding, MD, MPH, now executive vice president and chief patient officer for Merck, underscored the need for a "health security agenda," comprising both sustained leadership and funding, as well as clear communication and coordination, she said.
|
|
ABIPP Recognizes Your Knowledge and Expertise
The
American Board of Interventional Pain Physicians
(
ABIPP
) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become
ABIPP
certified.
ABIPP
now offers the only competency
certification program for regenerative medicine.
For complete information about the examination requirements and to obtain an application packet, visit
www.abipp.org
or call 270-554-9412 x4217 or by email at
summer@asipp.org
.
|
|
DATES
ABIPP Part I
- Theoretical written exam - October 3
ABIPP Part II
- Oral and Hands-on practical exam - October 3-4
ABIPP Competency Exam
- includes written, oral, and hands-on practical examinations October 3-4
Combined CSM/CCPM Exam for ABIPP Path
– October 3
Competency Exam in Controlled Substance Management
– October 3
Competency Exam in Coding, Compliance, and Practice Management
- October 3
Regenerative Medicine Competency Exam
- includes written, oral, and hands-on practical examinations – October 3-4
|
|
|
Sleep Predicts Migraine Recurrence
Sleep quality may identify patients at risk of developing
chronic migraine
Sleep quality at a single time point was tied to headaches occurring over the next 6 weeks among people with episodic migraine, a prospective study presented at the
American Headache Society
annual meeting showed.
Baseline poor sleep quality in episodic migraine patients was associated with a 22%
higher rate of headache recurrence
on each day over the following 6 weeks, reported Angeliki Vgontzas, MD, of Brigham and Women's Hospital in Boston, and co-authors.
|
|
|
|
May/June 2020
Issue Available
In this issue,
Pain Physician
includes randomized trials on cervical plexus blocks for endarterectomy, pulsed radiofrequency for hemiplegic shoulder pain, ultrasound-guided injection for meralgia paresthetica, and more.
|
|
Randomized Trial
Emiliano Petrucci, MD, Vincenza Cofini, MD, Barbara Pizzi, MD, Rosaria Coletta, MD, Angelo Geremia Blasetti, MD, Stefano Necozione, MD, Pierfrancesco Fusco, MD, and Franco Marinangeli, MD.
Randomized Trial
Ebru Alanbay, MD, Berke Aras, MD, Serdar Kesikburun, MD, Selvinaz Kizilirmak, MD, Evren Yasar, MD, and Arif Kenan Tan, MD.
Randomized Trial
Selda Kiliç, MD, Feyza Ünlü Özkan, MD, Duygu Geler Külcü, MD, Gülcan Öztürk, MD, Pinar Akpinar, MD, and Ilknur Aktas, MD.
Randomized Trial
Botao Liu, MD, Yang Yang, MD, Zhongyi Zhang, MD, Haining Wang, MD, Bifa Fan, MD, and
Lei Sima, MD.
|
|
VIEW ARCHIVED WEBINARS
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 6
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 5
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 4
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 3
Surviving the COVID-19 Epidemic: Protecting Family and Employees and Managing Financial Issues and Burnout – PART 2
Surviving the Coronavirus Pandemic: Practical Advice Every Pain Physician Needs to Know – PART 1
|
|
COVID-19 safety: Tips for leaving home
to travel, visit restaurants and more
If
coronavirus disease 2019 (COVID-19)
stay-at-home restrictions are easing in your community, you might wonder how to visit public places and protect your health. Here's what you need to know.
Before you head out
Follow guidance where you live. In the U.S., activity restrictions vary among cities and states. Before you head out, check your city or state health department's website for information about local restrictions aimed at preventing the spread of the COVID-19 virus.
|
|
Study is first to identify potential therapeutic targets for COVID-19
A team from Lawson Health Research Institute and Western University are the first in the world to profile the body's immune response to COVID-19. By studying blood samples from critically ill patients at London Health Sciences Centre (LHSC), the research team identified a unique pattern of six molecules that could be used as therapeutic targets to treat the virus. The study is published this week in Critical Care Explorations.
Since the pandemic's start there have been reports that the immune system can overreact to the virus and cause a cytokine storm - elevated levels of inflammatory molecules that damage healthy cells.
|
|
COVID-19 Antibody Tests:
Reply Hazy, Try Again
Six months into a global outbreak, data quality remains a problem
|
|
COVID-19 antibody tests
-- at least, those on the market through April -- had a window for accuracy of only a few weeks after symptom onset, and little reliable data beyond that point, a Cochrane review found.
In a review of 54 available studies through the end of April, mostly from China, the accuracy of pooled results for combination immunoglobulin (Ig)G/IgM tests was 91.4% (95% CI 87.0-96.6) for 15-21 days post-symptom onset, reported Jonathan Deeks, PhD, of the University of Birmingham in the U.K., and colleagues.
|
|
Dying Alone During COVID;
The Trauma of This Moment
Also, a lottery system for allocating scarce resources?
|
|
ASIPP
®
Partners with Fedora Billing And Revenue Cycle Management Company
|
|
ASIPP is now able to offer unique benefits for revenue cycle management with billing, etc.
Fedora
is a company known to many of our board members and others.
ASIPP
®
has reached an agreement with Fedora to provide exclusive discounts on billing or revenue cycle management that will decrease practice costs and promote growth, or at least stop deterioration. It is not just a billing company; they streamline the billing and receivable process and constantly update payor regulations keeping your practice up to on date on a daily basis.
Some of the
ASIPP
®
Billing Program highlights are below:
Up to 50% savings for
ASIPP
®
members for their billing or revenue cycle management for their offices and surgery centers:
- Expertise in interventional pain management billing for all types of services
- 99% Clearing House Rate
- 95% First-Time Claim Passage
- 23.4 Average Days in A/R
- Eligibility and Benefits Verification
- Pre-Certification/Prior Authorization
- Denials and A/R Management
|
|
Join The Group Purchasing
Organization Today
|
|
ASIPP
®
has formed a partnership with
Henry Schein
and
PedsPal
, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today. While the cost of contrast media has skyrocketed due to the single dose vial issue, because we have partnered with Henry Schein, this could enable you to purchase Omnipaque 240mg/50mL for slightly above $4.50.
It will be easy for
ASIPP
®
members in good standing to enroll today and begin to realize the savings this partnership can bring. Members can join or see sample prices by going to
http://pedspal.org/asipp/default.html
Click on “view our discounted supplier prices” (Username: ASIPPmember and Password: Save) or click on the words "join for free now" and begin saving today!
|
|
‘Cries for help’: Drug overdoses are soaring during the coronavirus pandemic
Suspected overdoses nationally jumped 18 percent in March, 29 percent in April and 42 percent in May, data from ambulance teams, hospitals and police shows.
The bodies have been arriving at Anahi Ortiz’s office in frantic spurts — as many as nine overdose deaths in 36 hours. “We’ve literally run out of wheeled carts to put them on,” said Ortiz, a coroner in Columbus, Ohio.
In Roanoke County, Va., police have responded to twice as many fatal overdoses in recent months as in all of last year.
In Kentucky, which just celebrated its first decline in overdose deaths after five years of crisis, many towns are experiencing an abrupt reversal in the numbers.
|
|
A Proposed Lottery System to Allocate Scarce COVID-19 Medications Promoting Fairness and Generating Knowledge
|
|
On May 1, 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization for the unapproved drug remdesivir to treat hospitalized patients with severe coronavirus disease 2019 (COVID-19). The authorization was based on a preliminary report from a randomized clinical trial in 1063 patients that found that remdesivir shortened the median time to recovery from 15 days to 11 days.
1
Anticipating immediate worldwide demand, the maker of remdesivir, Gilead Sciences, donated 1.5 million doses of remdesivir to countries affected by the pandemic, including the US, which received 607 000 doses (enough to treat approximately 100 000 patients).
However, the US and other countries have 2 major problems related to this drug. First, the supply of remdesivir is insufficient to treat all eligible patients, which has required hospitals to ration the drug.
2
Second, there remain major gaps in knowledge about the efficacy of remdesivir, including whether it reduces mortality and what subgroups of patients may benefit the most.
|
|
Essentials of Regenerative Medicine in Interventional
Pain Management
|
|
|
|
Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine in managing chronic pain. Regenerative medicine is an integral part of interventional pain management within the definitions of interventional pain management and interventional techniques.
Each chapter contains an introduction of the subject, historical context,pathophysiology, applicability of regenerative medicine with its evidence base, indications, anatomy, technical aspects, complications, and precautions for each topic when available and applicable. This comprehensive book consists of 35 chapters, more than 350 figures, and 50 tables.
|
|
|
ORDER
|
Essentials of Regenerative Medicine in IPM
|
|
Regenerative Medicine for Spine Disease
On Demand Course covering Biologics in the treatment of DDD and Back Pain PRP, Bone Marrow Aspirate ASIPP Guidelines, Theory and Evidence Ultrasound Bone Marrow Aspirate PRP preparation. Video includes 1 CME Credit. Learn More. [
https://painexam.com/events/
]
|
|
Control Your Waiting Room TV
Customized waiting room TV exclusively for
ASIPP
®
members. Create your own ad-free television broadcasts using our videos, custom informational slides and your own YouTube videos. Even add local weather reports, news and live messages.
|
|
|
|
|
|
GSIPP 16th Annual Pain Summit
|
|
The Ritz-Carlton Reynolds Plantation
Lake Oconee
|
|
|
|
|
|
|
2020 12th Annual Scientific
Meeting
|
|
|
|
|
|
|
|
|
|
